These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8995543)
1. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer. Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of CD44 splice variant expression in premalignant lesions of the cervix and benign cervical epithelium. Kohlberger PD; Kieback DG; Bancher D; Stickeler E; Heinzl H; Gitsch G; Breitenecker G; Kainz C Gynecol Oncol; 1997 Aug; 66(2):227-32. PubMed ID: 9264567 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours. Saegusa M; Hashimura M; Machida D; Okayasu I J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092 [TBL] [Abstract][Full Text] [Related]
4. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study. Faleiro-Rodrigues C; Lopes C Pathobiology; 2004; 71(6):329-36. PubMed ID: 15627844 [TBL] [Abstract][Full Text] [Related]
5. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium. Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903 [TBL] [Abstract][Full Text] [Related]
6. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression. Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431 [TBL] [Abstract][Full Text] [Related]
7. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer. Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T Eur J Cancer; 1998 Dec; 34(13):2107-11. PubMed ID: 10070319 [TBL] [Abstract][Full Text] [Related]
8. CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma. Gorham H; Woodman A; Goodison S; Marsh J; Charnock M; Manek S; Sugino T; Tarin D Mol Diagn; 1999 Mar; 4(1):45-56. PubMed ID: 10229774 [TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 in uterine cervical squamous neoplasia: a predictor of microinvasion? Callagy G; O'Grady A; Butler D; Leader M; Kay E Gynecol Oncol; 2000 Jan; 76(1):73-9. PubMed ID: 10620445 [TBL] [Abstract][Full Text] [Related]
10. Distribution of CD44 variant isoforms in human skin: differential expression in components of benign and malignant epithelia. Hale LP; Patel DD; Clark RE; Haynes BF J Cutan Pathol; 1995 Dec; 22(6):536-45. PubMed ID: 8835172 [TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis. Koyama S; Maruyama T; Adachi S J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277 [TBL] [Abstract][Full Text] [Related]
12. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation. Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088 [TBL] [Abstract][Full Text] [Related]
13. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Nguyen VN; Mirejovský T; Melinová L; Mandys V Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866 [TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia. Dellas A; Schultheiss E; Almendral AC; Torhost J; Gudat F Gynecol Oncol; 1996 Aug; 62(2):218-25. PubMed ID: 8751553 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer. Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CD44 splice variants in human stage III cervical cancer. Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of CD44v6 in adenocarcinoma of the pancreas: an immunohistochemical study. Castellà EM; Ariza A; Ojanguren I; Mate JL; Roca X; Fernández-Vasalo A; Navas-Palacios JJ Virchows Arch; 1996 Nov; 429(4-5):191-5. PubMed ID: 8972753 [TBL] [Abstract][Full Text] [Related]
18. CD44 loss in gastric stromal tumors as a prognostic marker. Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305 [TBL] [Abstract][Full Text] [Related]
19. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients. Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709 [TBL] [Abstract][Full Text] [Related]
20. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence. Gilcrease MZ; Guzman-Paz M; Niehans G; Cherwitz D; McCarthy JB; Albores-Saavedra J Cancer; 1999 Dec; 86(11):2320-6. PubMed ID: 10590373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]